Trials / Completed
CompletedNCT00302510
Therapeutic Effect of Immunoadsorption for Patients With Lipoprotein Glomerulopathy
Therapeutic Effect of Immunoadsorption for Patients With Lipoprotein
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Nanjing University School of Medicine · Academic / Other
- Sex
- All
- Age
- 15 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to assess the efficacy and safety of immunoadsorption in the treatment of lipoprotein glomerulopathy.
Detailed description
Lipoprotein glomerulopathy is characterized by nephritic syndrome glomerular protein thrombi and lipid abnormalities, particularly with an elevated level of plasma apoprotein E (apoE).There are no efficiency way to treat lipoprotein glomerulopathy. We firstly successfully treat 2 patients by protein A immunoadsorption with remarkable decreased urine protein and reduction of lipoprotein thrombi on repeated renal biopsy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | immunoadsorption | immunoadsorption |
Timeline
- Start date
- 2000-01-01
- Primary completion
- 2002-03-01
- Completion
- 2003-08-01
- First posted
- 2006-03-14
- Last updated
- 2010-05-27
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT00302510. Inclusion in this directory is not an endorsement.